HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Qinfu Feng Selected Research
Qinfu Feng Research Topics
Disease
23
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 04/2010
23
Esophageal Squamous Cell Carcinoma
01/2023 - 05/2014
13
Esophageal Neoplasms (Esophageal Cancer)
01/2023 - 09/2015
12
Neoplasms (Cancer)
01/2023 - 05/2014
5
Radiation Pneumonitis
01/2022 - 10/2005
4
Breast Neoplasms (Breast Cancer)
10/2023 - 12/2015
4
Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 06/2014
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2014
4
Neoplasm Metastasis (Metastasis)
01/2019 - 12/2011
4
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2017 - 11/2002
3
Hepatocellular Carcinoma (Hepatoma)
10/2023 - 01/2022
3
Margins of Excision
03/2022 - 01/2021
3
Lung Neoplasms (Lung Cancer)
01/2022 - 10/2005
3
Carcinoma (Carcinomatosis)
11/2021 - 09/2019
3
Thymoma (Thymic Carcinoma)
10/2021 - 08/2013
3
Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2021 - 05/2014
2
Pneumonia (Pneumonitis)
01/2023 - 01/2021
2
Lymphatic Metastasis
02/2020 - 06/2014
2
Brain Neoplasms (Brain Tumor)
12/2018 - 06/2014
2
Weight Loss (Weight Reduction)
04/2010 - 10/2005
1
Hypoxia (Hypoxemia)
01/2023
1
Carcinosarcoma
10/2022
1
Seminoma
03/2022
1
Lymphopenia (Lymphocytopenia)
01/2022
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022
1
Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
10/2021
1
Thymus Neoplasms (Thymus Neoplasm)
10/2021
1
Adenoid Cystic Carcinoma (Cylindroma)
01/2021
1
Residual Neoplasm
09/2020
1
Pathologic Complete Response
02/2020
1
Glioma (Gliomas)
12/2018
1
Adenocarcinoma
12/2016
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2007
1
Esophagitis
10/2005
Drug/Important Bio-Agent (IBA)
4
Immune Checkpoint Inhibitors
IBA
01/2023 - 01/2021
2
Antigens
IBA
01/2023 - 08/2018
2
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 01/2021
2
Tyrosine Kinase Inhibitors
IBA
01/2022 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2021
2
Tumor Biomarkers (Tumor Markers)
IBA
08/2018 - 06/2014
1
nimotuzumab
IBA
01/2023
1
Carbohydrates
IBA
01/2023
1
B7-H1 Antigen
IBA
01/2023
1
toripalimab
IBA
01/2023
1
Alprostadil (Muse)
FDA Link
Generic
12/2018
1
Phosphopyruvate Hydratase (Enolase)
IBA
08/2018
1
antigen CYFRA21.1
IBA
08/2018
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
06/2014
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
04/2010
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2007
Therapy/Procedure
48
Radiotherapy
10/2023 - 01/2007
18
Chemoradiotherapy
01/2023 - 03/2015
13
Drug Therapy (Chemotherapy)
01/2023 - 10/2005
10
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2022 - 01/2015
9
Therapeutics
01/2023 - 11/2002
9
Esophagectomy
01/2022 - 12/2014
6
Neoadjuvant Therapy
01/2022 - 07/2015
5
Adjuvant Radiotherapy
03/2022 - 08/2013
4
Adjuvant Chemotherapy
08/2021 - 12/2014
4
Conformal Radiotherapy
05/2021 - 10/2005
2
Immunotherapy
01/2023 - 01/2023
1
Hepatectomy
08/2022
1
Palliative Care (Palliative Therapy)
09/2020
1
Salvage Therapy
02/2020
1
Consolidation Chemotherapy
01/2020
1
Pneumonectomy (Lung Volume Reduction)
05/2019
1
Contraindications
01/2019
1
Segmental Mastectomy (Lumpectomy)
12/2015